The DIGI-B-CUBE project aims to foster the development of customized solutions and prototypes for the healthcare sector.
In April 2018, Oslo Cancer Cluster and 8 European partners submitted a proposal titled “Digital Enterprise Innovations for Bioimaging, Biosensing and Biobanking Industries (DIGI-B-CUBE)” to Horizon 2020 – an EU research and innovation funding programme. The proposal was approved and the EU commission granted approximately 5 million euro to the DIGI-B-CUBE consortium.
The DIGI-B-CUBE project will foster the development of customized solutions and prototypes for the healthcare sector. The project will provide innovative small and medium-sized enterprises (SME) in the EU and associated countries with access to vouchers of up to €60,000. SMEs have also engaged in the project by participating in the sectoral and cross-sectoral workshops as well as matchmaking sessions.
DIGI-B-CUBE Open Call for Proposals for Innovation Projects
DIGI-B-CUBE project is launching an open call for funding on 22nd April 2020, to support projects focusing on integrating digital innovations and disruptive technologies across the Medical Diagnostics and related value chains. Small and Medium Enterprises (including new start-ups) operating in the health, medicine, biotech, biopharma, IT or related sectors (robotics, automation, electronics, nanotech etc.) can apply for equity-free funding up to €60,000 through the DIGI-B-CUBE voucher scheme.
You can also visit the official DIGI-B- CUBE website to find out more about the open calls.
What is “B-CUBE”?
“B-CUBE” is an abbreviation for bioimaging, biosensing and biobanking.
- Bioimaging, or biological imaging, refers to when creating images of the human body or parts of it to diagnose or examine disease.
- Biosensing is the measurement of a chemical substance, for example glucose monitoring in diabetes patients or other medical health related targets.
- Biobanking is the storing of human biological samples so that they can be used for medical research later.
The large and complex datasets derived from these fields will require automated medical diagnostic processes. Digitalization solutions will reconfigure how health treatment is provided and will lead to more effective diagnosis and will enable personalized medicine.
For more information:
Gupta Udatha, Director (Digital and EU), Oslo Cancer Cluster
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 824920.